Conformal Medical’s CLAAS® System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices

Conformal Medical is actively enrolling patients in the CONFORM pivotal trial, evaluating the safety and efficacy of the CLAAS System compared to other commercially available LAAO devices. The prospective, multicenter, randomized controlled study will enroll approximately 1,600 patients.